Evidence map›Paper›PMID 38250875›Full record

ArticleVaccines2024

Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review.

Emmy Marjorie Carvalho de Araújo, Marcos Adriano Garcia Campos, Andressa Monteiro Sodré, Maria Izabel de Holanda, Rodrigo Hagemann, Antonio Augusto Lima Teixeira Júnior, Natalino Salgado Filho, Precil Diego Miranda de Menezes Neves, Gyl Eanes Barros Silva

Open access · goldAbstract readCase Reports
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Emmy Marjorie Carvalho de AraújoFaculty of Medicine, Federal University of Maranhão, Gonçalves Dias Square, São Luís 65020-240, Brazil.
Marcos Adriano Garcia CamposClinical Hospital of Botucatu Medical School, São Paulo State University, Professor Mário Rubens Guimarães Montenegro Avenue, Botucatu 18618-687, Brazil.
Andressa Monteiro SodréFaculty of Medicine, Federal University of Maranhão, Gonçalves Dias Square, São Luís 65020-240, Brazil.
Maria Izabel de HolandaBonsucesso Federal Hospital, Londres Avenue, Rio de Janeiro 21041-020, Brazil.
Rodrigo HagemannClinical Hospital Complex, Federal University of Paraná, General Carneiro Street, Curitiba 80060-900, Brazil.
Antonio Augusto Lima Teixeira JúniorDepartament of Genetics, Ribeirão Preto Medical School, University of São Paulo, Bandeirantes Avenue, Ribeirão Preto 14040-900, Brazil.ORCID 0000-0002-0072-6202
Natalino Salgado FilhoFaculty of Medicine, Federal University of Maranhão, Gonçalves Dias Square, São Luís 65020-240, Brazil.
Precil Diego Miranda de Menezes NevesClinical Hospital, University of São Paulo, Dr. Ovídio Pires de Campos Street, São Paulo 05403-010, Brazil.
Gyl Eanes Barros SilvaFaculty of Medicine, Federal University of Maranhão, Gonçalves Dias Square, São Luís 65020-240, Brazil.ORCID 0000-0001-6625-6488
Universidade de São Paulo · BRUniversidade Federal do Maranhão · BRHospital Geral de Bonsucesso · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large-scale COVID-19 vaccination has been one of the most effective strategies to control the spread of the SARS-CoV-2 virus. However, several cases of glomerular injury related to the COVID-19 vaccine have been described in the literature. We report two cases of a tip lesion variant of focal segmental glomerulosclerosis (FSGS), which presented with significant proteinuria and improved after immunosuppression. In our literature review, the tip lesion variant of FSGS is currently the most frequent variant associated with vaccination against COVID-19. Prognosis is favorable and without significant alterations in the tubulointerstitial or vascular compartments. Adverse effects of vaccines need to be recognized early and will help us to understand the immune and pathological mechanisms of kidney damage.

Indexed as

COVID-19focal segmental glomerulosclerosiskidney biopsySARS-CoV-2vaccine

Identifiers

PMID38250875
PMCPMC10821173
OpenAlexW4390662182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.